-- Susan A. Greene, CRA, Grants & Contracts Administrator, Medical University of South Carolina, Research & Sponsored Programs, 19 Hagood Ave., Suite 606 (express), Mailbox 250808 (U.S. Postal), Charleston, SC 29425-0808 (express, use, 29425), PH: 843-792-2040, FX: 843-792-6447
Special instructions in RFAs / PAs et al., even from individual institutes, have always trumped the PHS398 instructions, so following the specific FOA instructions is not really a new concept. I just think folks were expecting a little more consistency than what is actually occurring and perhaps were caught by surprise for some changes in the application itself other than moving from paper to electronic. -- Evelyn
At 03:34 PM 6/28/2006, Charlie Hathaway wrote:
I would not recommend this as a solution to what the PIs are clearly (but I think misguidedly) viewing as a mistake on NIH's part. We all know the grantsmanship principle of never expecting a reviewer to look at the Appendix. In this case, an argument begun on the first page of the Intro (placed in its proper position in the proposal) is separated from its conclusion (stuck in the appendix). I'd be worried about getting a proper read.
Better to give a one pager and refer to expanded discussion elsewhere. Of course this could...and should...be viewed as circumventing the page limitations.
CH
At 03:12 PM 6/28/2006, you wrote:
I submitted an R21 this week and received an error for the introduction section being 3 pages long. The PI asked me to put the other two pages of his introduction in the appendix. I submitted his application with one page in the introduction and the other two pages in the appendix section and it worked fine.
Sheri L. Mundy
Grant Specialist
Sponsored Research Services
Indiana University
From: Research Administration List [ mailto:xxxxxx@hrinet.org] On Behalf Of Kristen Wolff
Sent: Wednesday, June 28, 2006 2:52 PM
To: xxxxxx@hrinet.org
Subject: Re: [RESADM-L] Intro to revised R21
Debbie et al, what about the idea of cutting the intro to the bare necessities and then including the full (3 page) intro in the appendix? Has anyone done that?
thanks
Kris
From: Research Administration List [ mailto:xxxxxx@hrinet.org] On Behalf Of Debbie Smith
Sent: Wednesday, June 28, 2006 11:12 AM
To: xxxxxx@hrinet.org
Subject: Re: [RESADM-L] Intro to revised R21
I am telling my folks that if their program officer says they can submit 3 pages for the intro, they should cut it to one for the electronic submission and send the revised intro later. If they don't cut it to one page now, it will not go in and will never get to the program officer!
Debbie
Deborah (Debbie) L. Smith, Ed.D.
Director, Research Administration
UT Health Science Center
910 Madison, Suite 823
Memphis, TN 38163
901 448-4823
901 448-7600 fax
xxxxxx@utmem.edu
----- Original Message -----
From: Carolyn Elliott-Farino
To: xxxxxx@hrinet.org
Sent: Wednesday, June 28, 2006 11:56 AM
Subject: Re: [RESADM-L] Intro to revised R21
Ah ha so R 21s are shorter in length for both the research plan and the introduction. That sort of makes sense. :o)
It is correct that PA instrux trump the general, but what a pain. The "Follow page limitations as specified in PAs and RFAs" instruction is immediately below the page limitations for the research plan, not the intro instrux. Arghh!! Lesson is, as Charlie says, PA instructions trump the SF424 guide!
Oh well. Happy midweek.
>>> xxxxxx@PHI.ORG 6/28/2006 12:45:27 PM >>>
The following is from the Parent Application, PA-06-181. Unfortunately,
it contradicts the SF 424 R&R Application Guide. I have a new
investigator whose program officer told her three pages was allowed, so
I appreciate the advance warning!
PA-06-181
Application Characteristics
All application instructions outlined in the SF424 (R&R) application are
to be followed, with the following requirements for R21 applications:
R21 applications will use the modular budget format and "Just-in-Time"
concepts, with direct costs requested in $25,000 modules, up to the
total direct costs limitation of $275,000 over an R21 two-year period.
No more than $200,000 in direct costs will be allowed in any single
year.
Items 2-5 of the Research Plan of the R21 application may not exceed 15
pages, including tables, graphs, figures, diagrams, and charts.
Introduction (required for a resubmission application) is limited to one
page.
Preliminary data are not required but may be included if available.
Judith Lubina
direct tel: 510.285.5568
main tel: 510.285.5500
fax: 510.285.5501
-----Original Message-----
From: Research Administration List
====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================------------------------------------------------------------------
If this e-mail has multiple recipients, please use
"reply to all" when responding, if appropriate.
------------------------------------------------------------------
Evelyn J. Ford, Associate Director, ORSS
270 Anat-Chem
voice 215.573.1395 fax 215.573.8802
xxxxxx@mail.med.upenn.edu
http://www.med.upenn.edu/orss/
http://www.med.upenn.edu/research/penn/====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================